Addressing Obesity in Diabetes

Hales CM Carroll MD Fryar CD Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017-2018. NCHS Data Brief. 2020;360:1-8. https://www.cdc.gov/nchs/data/databriefs/db360-h.pdf

Ward ZJ Bleich SN Cradock AL , et al. Projected US state-level prevalence of adult obesity and severe obesity. N Eng J Med. 2019;381(25):2440-2450. doi:10.1056/NEJMsa1909301

Finkelstein EA Khavjou OA Thompson H , et al. Obesity and severe obesity forecasts through 2030. Am J Prev Med. 2012;42(6):563-570.

Amati F Pennant M Azuma K , et al. Lower thigh subcutaneous and higher visceral abdominal adipose tissue content both contribute to insulin resistance. Obesity. 2012;20:1115-1117.

Tremmel M Gerdtham U Nilsson P , et al. Economic burden of obesity: a systematic literature review. Int J Environ Res Public Health. 2017;14(4):435. doi:10.3390/ijerph14040435

Recio-Rodriguez JL Gomez-Marcos MA Patino-Alonso MC. Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics, and hypertensive. BMC Cardiovasc Disord. 2012;12:3. doi:10.1186/1471-2261-12-3

Padula W Allen R Nair K. Determining the cost of obesity and its common comorbidities from a commercial claims database. Clin Obes. 2014;4(1):53-58.

Wander PL Boyko EJ Leonetti DL , et al. Change in visceral adiposity independently predicts a greater risk of developing type 2 diabetes over 10 years in Japanese Americans. Diabetes Care. 2012;36(2):289-293.

Kim DD Basu A. Estimating the medical care costs of obesity in the United States: systematic review, meta-analysis, and empirical analysis. Value Health. 2016;19(5):602-613. doi:10.1016/j.jval.2016.02.008

Leung M Carlsson N Colditz G , et al. The burden of obesity on diabetes in the United States: medical expenditure panel survey, 2008 to 2012. Value Health. 2017;20(1):77-84. doi:10.1016/j.jval.2016.08.735

Slagter S van Vliet-Ostaptchouk J van Beek A , et al. Health-related quality of life in relation to obesity grade, type 2 diabetes, metabolic syndrome and inflammation. PLoS One. 2015;10(10):e0140599. doi:10.1371/journal.pone.0140599

Franz MJ Boucher JL Evert AB. Evidence-based diabetes nutrition therapy recommendations are effective: the key is individualization. Diabetes Metab Syndr Obes. 2014; 7:65-72.

Dugan JA. Exercise recommendations for patients with type 2 diabetes. JAAPA. 2016;29(1):13-18; quiz 1. doi:10.1097/01.JAA.0000475460.77476.f6

American Medical Association. Recognition of obesity as a disease H-440.842. AMA recognizes obesity as a disease state with multiple pathophysiological aspects requiring a range of interventions to advance obesity treatment and prevention. Res. 420, A-13. Reaffirmed: CSAPH Rep. 08, A-23. https://policysearch.ama-assn.org/policyfinder/detail/obesity?uri=%2FAMADoc%2FHOD.xml-0-3858.xml

Chapman C Benedict C Brooks SJ Schioth HB. Lifestyle determinants of the drive to eat: a meta-analysis. Am Clin Nutr. 2012;96(3):492-497. doi:10.3945/ajcn.112.039750

Yu JH Kim M-S. Molecular mechanisms of appetite regulation. Diabetes Metab J. 2012;36(6):391-398. doi:10.4093/dmj.2012.36.6.391

Feng H Zheng L Feng Z Zhao Y Zhang N. The role of leptin in obesity and the potential for leptin replacement therapy. Endocrine. 2013;44(1):33-39. doi:10.1007/s12020-012-9865-y

Perry B Wang Y. Appetite regulation and weight control: the role of gut hormones. Nutr Diabetes. 2012;2(1):e26. doi: 10.1038/nutd.2011.21

Erion KA Corkey BE. Hyperinsulinemia: a cause of obesity? Curr Obes Rep. 2017;6(2)178-186. doi:10.1007/s13679-017-0261-z

Upadhyaya S Banerjee G. Type 2 diabetes and gut microbiome: at the intersection of known and unknown. Gut Microbes. 2015;6(2):85-92. doi:10.1080/19490976.2015.1024918

Le Chatelier E Nielsen T Qin J Prifti E , et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500:541-546. doi:10.1038/nature12506

Fang S Evans RM. Wealth management in the gut. Nature. 2013;500(7464):538-539. doi:10.1038/500538a

Komaroff AL. The microbiome and risk for obesity and diabetes. JAMA. 2017;317(4):355-356. doi:10.1001/jama.2016.20099

Jackson M Goodrich J Maxan M , et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut. 2015;65(5):749-756.

Sheetal RM Collins JJ Relman DA. Antibiotics and thegut microbiota. J Clin Invest. 2014;124(10):4212-4218. doi:10.1172/JCI72333

Garvey WT Mechanick JI Brett EM , et al. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical practice guidelines for comprehensive medical care of patients with obesity. Endocr Pract. 2016;22(suppl 3):1-203. doi:10.4158/EP161365.GL

Centers for Disease Control and Prevention. National diabetes statistics report. Centers for Disease Control and Prevention. US Dept of Health and Human Services; 2020. Updated June 29, 2022. Accessed September 30, 2022. https://www.cdc.gov/diabetes/data/statistics-report/prevalence-of-predi-abetes.html#:~:text=Among%20US%20adults%20aged%2018,A1C%20level%20(Table%203)

Hirode G Wong RJ. Trends in the prevalence of metabolic syndrome in the United States, 2011-2016. JAMA. 2020;323(24):2526-2528. doi:10.1001/jama.2020.4501

Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2012;59(7):635-643. doi:10.1016/j.jacc.2011.08.080

Ali MK Echouffo-Tcheugui J Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the diabetes prevention program? Health Aff (Millwood). 2012;31(1):67-75.

Lindstrom J Ilanne-Parikka P Peltonen M , et al; Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673-1679. doi:10.1016/S0140-6736(06)69701-8

Li G Zhang P Wang J , et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371:1783-1789.

Knowler WC Fowler SE Hamman RF , et al; Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677-1686.

Knowler WC Barrett-Connor E Fowler SE , et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:3930403. doi:10.1056/N E JMoa012512

Fedewa MV Gist NH Evans EM Dishman RK. Exercise and insulin resistance in youth: a meta-analysis. Pediatrics. 2014;133(1):e163-174. doi:10.1542/peds.2013-2718

Davis CL Pollock NK Waller JL , et al. Exercise dose and diabetes risk in overweight and obese children: a randomized controlled trial. JAMA. 2012;308(11):1103-1112. doi:10.1001/2012.jama.10762

US Department of Health and Human Services. Managing Overweight and Obesity in Adults. Systematic Evidence Review From the Obesity Expert Panel. 2013.

American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Executive summary: guidelines for the management of overweight and obesity in adults. Obesity. 2014;22(2):S5-S39.

Franz MJ Boucher JL Rutten-Ramos S VanWormer JJ. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet. 2015;115(9):1447-1463.

Wilding JP. The importance of weight management in type 2 diabetes. Int J Clin Pract. 2014;68(6):682-692.

Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566-1575.

Redmon JB Bertoni AG Connelly S , et al. Effect of the Look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes. Diabetes Care. 2010;33(6):1153-1158.

Fallah-Fini S Adam A Cheskin LJ Bartsch SM Lee BY. The additional costs and health effects of a patient having overweight or obesity: a computational model. Obesity. 2017;25:1809-1815.

Powers M Bardsley J Cypress M , et al. Diabetes self-management education and support in type 2 diabetes. Diabetes Educ. 2017;43(1):40-53. doi:10.1177/0145721716689694

Hyer S Conner NE. Concept of overweight bias among healthcare professionals: an evolutionary concept analysis. Nurs Forum. 2020;55(3):395-402. doi:10.1111/nuf.12442

Rubino F Puhl RM Cummings DE , et al. Joint international consensus statement for ending stigma of obesity. Nat Med. 2020;26(4):485-497. doi:10.1038/s41591-020-0803-x

Puhl RM Lessard LM Himmelstein MS Foster GD. The roles of experienced and internalized weight stigma in healthcare experiences: perspectives of adults engaged in weight management across six countries. PLoS One. 2021;16(6):e0251566. doi:10.1371/journal.pone.0251566 .

Puhl RM Himmelstein MS Quinn DM. Internalizing weight stigma: prevalence and sociodemographic considerations in US adults. Obesity. 2018;26(1):167-175. doi:10.1002/oby.22029

Evert AB Brochu JL Cypress M , et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2013;36(11):3821-3842.

Cardel MI Newsome FA Pearl RL etc. Patient-centered care for obesity: how health care providers can treat obesity while actively addressing weight stigma and eating disorder risk. J Acad Nutr Diet. 2022;122(6):1089-1098. doi:10.1016/j.jand.2022.01.004

Pearl R Wadden TA Hopkins CM , et al. Association between weight bias internalization and metabolic syndrome among treatment-seeking individuals with obesity. Obesity 2017;25(2):317-322. doi:10.1002/oby.21716

Talumaa B Brown A Batterham RL Kalea AZ. Effective strategies in ending weight stigma in healthcare. Obes Rev. 2022;23(10):e13494. doi:10.1111/obr.13494

Tylka TL Annunziato RA Burgard D , et al. The weight-inclusive versus weight-normative approach to health: evaluating the evidence for prioritizing well-being overweight loss. J Obes. 2014;2014:983495. doi:10.1155/2014/983495

Association of Diabetes Care & Education Specialists. An effective model of diabetes care and education: the ADCES7 Self-Care Behaviors™. Sci Diabetes Self Manag Care. 2021;47(1):30-53. doi:10.1177/0145721720978154

American Medical Association. Person-first language for obesity H-440.821. Accessed August 2022. https://policysearch.ama-assn.org/policyfinder/detail/obesity?uri=%2FAMADoc%2FHOD.xml-0-3858.xml

Obesity Action Coalition. Accessed February 1, 2023. Stopweightbias.com https://stopweightbias.com/

Koball AM Mueller PS Craner J , et al. Crucial conversations about weight management with healthcare providers: patients’ perspectives and experiences. Eat Weight Disord. 2018;23(1):87-94. doi:10.1038/ijo.2012.110

Puhl R Peterson JL Luedicke J. Motivating or stigmatizing? Public perceptions of weight-related language used by health providers. Int J Obes. 2013;37(4):612-619. doi:10.1038/ijo.2012.110

Koball AM Clark MM Collazo-Clavell M , et al. The relationship among food addiction, negative mood, and eating-disordered behaviors in patients seeking to have bariatric surgery. Surg Obes Relat Dis. 2016;12(1):165-170. doi:10.1016/j.soard.2015.04.009

Fruh SM Nadglowski J Hall HR , et al. Obesity stigma and bias. J Nurse Pract. 2016;12(7):425-432. doi:10.1016/j.nurpra.2016.05.013

Centers for Disease Control and Prevention. Expert panel meeting on communicating about overweight/obesity with Hispanic American audiences. A meeting sponsored by the Centers for Disease Control and Prevention on July 14-15, 2016. https://stacks.cdc.gov/view/cdc/109297

Lynch EB Kane J. Body size perception among African American women. J Nutr Educ Behav. 2014;46(5):412-417.

Zestcott CA Blair IV Stone J. Examining the presence, consequences, and reduction of implicit bias in health care: a narrative review. Group Process Intergroup Relat. 2016;19(4):528-542.

Spruill IJ Magwood GS Nemeth LS Williams TH. African Americans’ culturally specific approaches to the management of diabetes. Glob Qual Nurs Res. 2015;2. doi:10.1177/2333393614565183

American Association of Diabetes Educators. AADE7™ Self-Care Behaviors. American Diabetes Educators Association. Published 2014. Accessed May 23, 2018. https://www.diabe-teseducator.org/docs/default-source/legacy-docs/_resources/pdf/publications/aade7_position_statement_final.pdf?sfvrsn=4

Kenkre J Tan T Bloom S. Treating the obese diabetic. Expert Rev Clin Pharmacol. 2013;6(2):171-183.

Mechanick JI Youdim A Jones DB , et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and non-surgical support of the bariatric surgery patient–2013 update: cosponsored by American Association of Clinical Endocrinolo-gists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity. 2013;21(01):S1-S27.

Medici V McClave S Miller A. Common medications which lead to unintended alterations in weight gain or organ lipotoxicity. Curr Gastroenterol Rep. 2016;18(1):1-12.

Yanovski SZ Yanovski JA. Long-term drug treatment for obesity a systematic and clinical review. JAMA. 2014;311(1):74-86.

Henry RR Chilton R Garvey WT. New options for the treatment of obesity and type 2 diabetes mellitus (narrative review). J Diabetes Complications. 2013;27(5):508-518.

Jensen MD Ryan DH Apovian CM , et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25,suppl 2):S102-138.

Stenlof K Cefalu WT Kim KA , et al. Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise. Diabetes Obes Metab. 2013;15(4):372-382.

Franz M MacLeod J Evert A Brown C , et al. Academy of Nutrition and Dietetics nutrition practice guideline for type 1 and type 2 diabetes in adults: a systematic review of evidence for medical nutrition therapy effectiveness and recommendations for integration into the nutrition care process. J Acad Nutr Diet. 2017;117(10):1659-1679. doi:10.1016/j.jand.2017.03.022

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Health information weight management prescription medications to treat overweight & obesity prescription medication for the treatment of obesity. Accessed September 2023. https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity

FDA approves new medication for chronic weight management [news release]; November 8, 2023. Accessed November 8, 2023. https://www.fda.gov/news-events/press-announcements/fda-approves-new-medicationchronic-weight-management

Obesity drugs: few adults used prescription drugs for weight loss and insurance coverage varied. GAO-19-577. Accessed September 30, 2022. https://www.gao.gov/assets/gao-19-577.pdf

Centers for Medicare & Medicaid Services. CMS: Part D coverage of anti-obesity medications with medically accepted indications. Accessed June 30, 2024. https:// www.cms.gov/about-cms/information-systems/hpms/hpms-memosarchive-weekly/hpms-memos-wk-4-march-18-22

Kyle TK Dhurandhar EJ Allison DB. Regarding obesity as a disease: evolving policies and their implications. Endocrinol Metab Clin North Am. 2016;45(3):511-520.

Bipartisan Policy Center. Expanding access to obesity treatment for older adults. Accessed September 30, 2022. https://bipartisanpolicy.org/download/?file=/wpcontent/uploads/2022/02/BPC_ExpandingAccessToObesityFinal.pdf

Maggard-Gibbons M Maglione M Livhits M , et al. Bariatric surgery for weight loss and glycemic control in nonmor-bidly obese adults with diabetes: a systematic review. JAMA. 2013;309(21):2250-2261.

Schauer PR Kashyap SR Wolski K , et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567-1576.

Edwards A Ensom MH. Pharmacokinetic effects of bariatric surgery. Ann Pharmacother. 2012;46(1):130-136. doi:10.1345/aph.1Q414

Vest AR Heneghan HM Schauer PR Young JB. Surgical management of obesity and the relationship to cardiovascular disease. Circulation. 2013;127(8):945-959.

Vest AR Heneghan HM Agarwal S Schauer PR Young JB. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98(24):1763-1777.69.

American Diabetes Association Professional Practice Committee. Introduction and methodology: Standards of Care in Diabetes — 2024. Diabetes Care. 2024;47(suppl 1):S1-S4. doi:10.2337/dc24-SINT

Grunvald E Shah R Hernaez R , et al. AGA clinical practice guideline on pharmacological interventions for adults with obesity. Gastroenterology. 2022;163(5):1198-1225. doi:10.1053/j.gastro.2022.08.045s